| Literature DB >> 29683948 |
Dilara F Kocacik Uygun1, Vedat Uygun2, Hayriye Daloğlu2, Seda Öztürkmen2, Gülsün Karasu2, İsmail Reisli3, Ersin Sayar4, Hasan A Yüksekkaya5, Erik-Oliver Glocker6, Kaan Boztuğ7, Akif Yeşilipek2.
Abstract
Mutations in interleukin-10 and its receptors cause infantile inflammatory bowel disease (IBD), a hyperinflammatory disorder characterized by severe, treatment-refractory colitis, multiple abscesses, and enterocutaneous fistulas. Patients with infantile IBD often require several surgical interventions, including complete colectomy, and hematopoietic stem cell transplantation is currently the only known medical therapy. Traditionally, operative management has been preferred before stem cell transplantation because of the latter's increased susceptibility to procedural complications; however, surgical intervention could be delayed, and possibly reconsidered, because our 2 patients with infantile IBD demonstrated a rapid response to treatment via engraftment.Entities:
Mesh:
Substances:
Year: 2019 PMID: 29683948 DOI: 10.1097/MPH.0000000000001165
Source DB: PubMed Journal: J Pediatr Hematol Oncol ISSN: 1077-4114 Impact factor: 1.289